|View printer-friendly version|
|Array BioPharma to Report Financial Results for the First Quarter Of Fiscal 2002 on November 5, 2001|
BOULDER, Colo., Oct. 29 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the first quarter of fiscal 2002 on Monday, November 5, 2001, at 4:30 p.m. eastern time and hold a conference call on Tuesday, November 6, 2001, at 9:00 a.m. eastern time. Robert E. Conway, Chief Executive Officer, and Michael Carruthers, Chief Financial Officer, will lead the call.
CONFERENCE CALL INFORMATION Date: Tuesday, November 6, 2001
Toll-Free: (800) 500-0177 Toll: (719) 457-2679 Web Cast: www.arraybiopharma.com
There will be a replay of the conference call for one week, which can be accessed by dialing toll-free (888) 203-1112, and outside the US (719) 457-0820. The access code is 636928. Replay of the call will also be available as a web cast on Array's web site at www.arraybiopharma.com.
Array BioPharma is a drug discovery company creating new drugs through the integration of chemistry, structural biology and chemoinformatics. We collaborate with leading pharmaceutical and biotechnology companies to identify novel small molecule drugs and are leveraging our discovery platform to develop our own pipeline of proprietary drug candidates. The Array scientific team has a proven track record of success in identifying promising drug candidates.
For more information on Array BioPharma, please visit the company's web site at www.arraybiopharma.com, or contact Tricia Haugeto of Array BioPharma Inc., (303) 386-1193, email@example.com.
SOURCE Array BioPharma Inc.
CONTACT: Tricia Haugeto of Array BioPharma Inc., +1-303-386-1193, firstname.lastname@example.org/